IP Library Granted Patent US 12691221
Granted Patent B2
US 12691221 · App. 16/789,162 · Granted Jul 28, 2026

Discretionary insulin delivery systems and methods

Inventor: Bryan Mazlish (Palo Alto, CA)
Assignee: Insulet Corporation
A61M5/1723A61B5/14532A61B5/4839A61M5/14244G16H20/17A61M2005/14208A61M2205/18A61M2205/3553A61M2205/3561A61M2205/3584A61M2205/3592A61M2209/01A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12691221
App. No.
16/789,162
Granted
Jul 28, 2026
Kind
B2
Abstract

A method of facilitating delivery of a discretionary dose of insulin to a user includes: enabling the user or a caregiver to specify, via a computer-based user interface, parameters associated with a discretionary delivery of insulin that may be delivered to the user; subsequently receiving data that represents the user's glucose level during a period of time associated with the discretionary delivery; automatically determining, with a computer-based processor, based on the received data, if, when and how much discretionary insulin should be delivered to the user during the period of time associated with the discretionary delivery; delivering insulin to the user during the period of time associated with the discretionary delivery according to the automatic determination; and delivering insulin to the user with the insulin delivery device according to a non-discretionary insulin delivery schedule unless a discretionary insulin delivery mode has been triggered.

Claims (12)

1 . A method, comprising:

receiving a user input defining a set of parameters of a discretionary insulin delivery mode of a system configured to deliver insulin to a user, wherein, when the system operates within the discretionary insulin delivery mode, the system, without further input from the user, is permitted to deliver discretionary insulin to the user according to a variable basal rate between an upper threshold basal rate and a lower threshold basal rate responsive to events associated with the user and within the defined set of parameters;

responsive to receiving an indication of an event associated with the user:

determining, via the system, the lower threshold basal rate to comprise a first basal rate that is lower than a constant basal rate of a non-discretionary insulin delivery that would have been delivered to the user according to a non-discretionary insulin delivery schedule absent receiving the indication of the event;

determining, via the system, the upper threshold basal rate to comprise a second basal rate that comprises the constant basal rate of the non-discretionary insulin delivery that would have been delivered to the user according to the non-discretionary insulin delivery schedule absent receiving the indication of the event in addition to a basal rate determined based on the indication of the event; and

starting the discretionary insulin delivery mode of the system and delivering an amount of the discretionary insulin to the user according to the variable basal rate; and

responsive to tracked discretionary insulin delivered to the user and a received glucose value, ceasing the discretionary insulin delivery mode of the system and delivering an amount of non-discretionary insulin to the user according to the non-discretionary insulin delivery schedule having the constant basal rate, wherein the system is not permitted to adjust the non-discretionary insulin delivery within the non-discretionary insulin delivery schedule.

2 . The method of claim 1 , wherein delivering the discretionary insulin to the user comprises delivering the discretionary insulin in addition to the non-discretionary insulin delivered according to the non-discretionary insulin delivery schedule.

3 . The method of claim 1 , wherein delivering the discretionary insulin to the user comprises delivering the discretionary insulin in lieu of the non-discretionary insulin delivered according to the non-discretionary insulin delivery schedule.

4 . The method of claim 1 , wherein ceasing the discretionary insulin delivery mode of the system comprises ceasing the discretionary insulin delivery mode of the system responsive to the tracked discretionary insulin indicating that a complete dosing of the discretionary insulin has been delivered to the user.

5 . The method of claim 1 , wherein ceasing the discretionary insulin delivery mode of the system comprises ceasing the discretionary insulin delivery mode of the system responsive to the tracked discretionary insulin indicating that a maximum amount of the discretionary insulin according to the user input set of parameters has been delivered within a time period.

6 . The method of claim 1 , wherein ceasing the discretionary insulin delivery mode of the system comprises ceasing the discretionary insulin delivery mode of the system responsive to the received glucose value indicating that a desired glucose level has been achieved.